UnitedHealthcare Zepbound Prior Authorization: 2026 Rules and Denial Fixes

Affiliate disclosure: Some links on this page are affiliate links. If you use them, The RX Index may earn a commission at no extra cost to you. Money never changes what the insurance rules say, what we recommend, or who we tell to walk away. Coverage is never guaranteed.

The RX Index is the independent GLP-1 decision resource that scores telehealth providers and treatment paths on clinical legitimacy, care quality, transparency, access, and cost, so readers can choose the path that fits their situation.

UnitedHealthcare Zepbound prior authorization follows three published commercial rule sets. The standard path uses BMI 30, or 27 plus a related condition; a narrow North Dakota path uses BMI 40; and the sleep-apnea path uses BMI 30 plus a qualifying sleep study. Each published path reviewed sits inside a UnitedHealthcare prior-authorization or notification program, but your plan must include or allow that path first. See the standard policy and the separate OSA policy.

A flawless prior authorization cannot create a benefit your plan excludes. But “excluded” does not always mean “over.” Some plans have a separate Zepbound path for moderate-to-severe obstructive sleep apnea.

UnitedHealthcare Zepbound prior authorization rules at a glance

This is the whole page in one table. Find your column, then read the section that matches it.

Sources: UnitedHealthcare Program 2026 P 1114-21, effective July 1, 2026, and Program 2025 P 1475-2, effective March 1, 2026. Both read in full August 6, 2026.

Look at the bottom row. That's the finding.

The path people call the “sleep apnea workaround” asks you to lose twice as much weight to keep your coverage. It also asks for a second test: your sleep-study number has to improve.

Age conflict in the source documents: UnitedHealthcare’s policy says “older than 16,” but the current FDA label covers adults and says Zepbound’s safety and effectiveness have not been established in pediatric patients. A 17-year-old should not read UHC’s age line as ordinary on-label eligibility. The prescriber and plan need to resolve that conflict before treatment.

Is this page for you?

Yes, if:

• The pharmacy said “this needs prior authorization” and sent you home empty-handed
• Your doctor's office is filing the request and you want to know what they need
• UnitedHealthcare denied it and you're trying to figure out why
• Your renewal got rejected
• Someone told you your plan “doesn't cover weight-loss drugs” and you want to know if that's the end of it

No, if:

• You want Zepbound dosing or side-effect information → read Is Zepbound Safe?
• Your insurer isn't UnitedHealthcare
• You're asking about Mounjaro for diabetes → UnitedHealthcare Mounjaro Prior Authorization
• You need a full Medicare-only answer → Does Medicare Cover Zepbound?
• You have a Community Plan or Medicaid card and need your state's rule → Does Medicaid Cover Zepbound?

The right GLP-1 provider isn't the same for everyone — it depends on your state, your insurance and formulary, whether you want an FDA-approved or compounded medication, your preferred treatment path (injection or oral), and your budget. Because a general answer can't resolve those for you, use The RX Index's Find My GLP-1 Path tool to get a personalized provider match with source-verified pricing before you choose.

What we actually checked

We're not going to tell you to trust us. Here's what we opened.

Documents and live pages checked on August 6, 2026:

• UnitedHealthcare Program 2026 P 1114-21 — “Prior Authorization/Notification – Plans with Weight Loss/Appetite Suppression Medication Coverage,” effective July 1, 2026
• UnitedHealthcare Program 2025 P 1475-2 — “Prior Authorization/Non-Formulary – Zepbound (tirzepatide) – Obstructive Sleep Apnea Only,” effective March 1, 2026
• The current Zepbound FDA prescribing information
• Two published Optum Rx 2026 client formularies with different Zepbound device results
• Current Optum Rx prior authorization procedures, including the fax retirement notice
• Current CMS Medicare Part D and Medicare GLP-1 Bridge rules
• Current federal internal-appeal and external-review guidance
• Current Ro coverage-checker scope and Ro Body pricing
• Current Sesame weight-management pricing and insurance-paperwork statement
• Current LillyDirect Zepbound self-pay pricing and refill terms

What these documents cannot tell you — and neither can we:

• Whether your specific plan covers Zepbound
• Whether your employer bought the weight-loss drug benefit
• Whether you personally meet the medical criteria
• Whether the reviewer will say yes
• Exactly how many days your commercial plan will take to decide
• Which paper form your plan uses
• Whether the device written on your prescription matches the device your plan covers

Your plan documents beat everything on this page. We'll show you how to read them.

Does UnitedHealthcare cover Zepbound and require prior authorization?

Some UnitedHealthcare plans cover Zepbound. The current standard commercial policy is a prior-authorization/notification program, while the separate OSA policy uses prior authorization and a non-formulary review. A UHC card by itself does not prove you have the benefit: the standard weight-loss program is optional, and the OSA path applies only when its separate rules fit.

UnitedHealthcare describes its standard program as “an optional program” for clients or businesses that elected to cover weight-loss products with prior authorization.

Read that again. It's optional. Your employer or plan chose to include it, or chose not to.

That single line explains why two people with UnitedHealthcare cards can get two different answers. They may have different employers, different formularies, different states, different lines of business, or different covered uses.

“Prior authorization required” does not mean you're approved

It means a review is possible. That's genuinely better than a flat benefit exclusion — but it's not a yes.

“Excluded” does not always mean it's over

A plan that excludes Zepbound for ordinary weight management may still have another path for its FDA-approved obstructive sleep apnea use. Medicare and some state programs also run their own rules.

The pharmacy rejection is not the full answer

The pharmacist may see a short message such as “PA required,” “non-formulary,” or “excluded.” Those words lead to different fixes. Get the full wording before anybody sends another form.

Which UnitedHealthcare Zepbound rule set applies to you?

The right rule set depends on your benefit, plan type, state, covered use, and sometimes the exact Zepbound device. Start with the exact wording on the pharmacy rejection, member portal, or denial letter. Do not let “not covered,” “non-formulary,” and “prior authorization required” get collapsed into one answer.

Rule set 1 — your plan includes weight-loss medication coverage

This is the standard path. It uses the BMI 30 or BMI 27-plus-a-condition rules below.

If the benefit exists, the request still has to prove you meet the policy. If the benefit does not exist, a thicker medical packet does not create it.

Rule set 2 — North Dakota fully insured EHB small-group or individual coverage

There's a narrow exception in the same policy. It applies to North Dakota fully insured Essential Health Benefit plans in the small-group and individual markets.

There, the number is BMI 40. Not 30.

And the “BMI 27 plus a condition” door does not appear in that section. The weight-management path is BMI 40.

Ten BMI points apart, in one insurer's document, in the same year. If you're in North Dakota on the named plan type and someone quoted you “BMI 30,” they may be reading the wrong section.

This does not apply to every plan sold in North Dakota.

Rule set 3 — your plan excludes weight-loss drugs, but you have moderate-to-severe OSA

Then the separate sleep-apnea policy may be your insurance path. It is legitimate. It is also much stricter.

Medicare and Community Plan are separate

Do not apply the commercial table to a UHC Medicare or Community Plan card. Medicare Part D, the Medicare GLP-1 Bridge, and each state's Medicaid rules have different criteria and deadlines.

How to find out which one is yours

1. Log in to myuhc.com. Search your plan's drug list for Zepbound and read the notes beside the exact product.
2. Check your Summary of Benefits and Coverage or Evidence of Coverage. Search for “weight loss,” “obesity,” “anti-obesity,” “exclusion,” and “prior authorization.”
3. Ask HR or your benefits team whether your employer plan includes weight-loss medication coverage.
4. Call the pharmacy-benefit number on the back of your card and use the script below.
5. Ask the prescriber's office to run the member-specific electronic request before relying on a generic form from the internet.

The phone script that gets a usable answer

Most people call and ask “is Zepbound covered?” That question can produce a vague answer. Ask these instead. Copy and paste them.

“I'm calling about Zepbound under my pharmacy benefit. One — is Zepbound excluded from my benefit, not on the formulary, or covered with prior authorization? Those are three different things and I need to know which one. Two — which policy or criteria document applies to my plan and this diagnosis? Three — is Optum Rx my pharmacy benefit manager? Four — which Zepbound device and NDC does my plan cover: the single-dose pen, vial, or KwikPen? Five — what exact electronic submission path or current form should my prescriber use? Six — what records do you require? And if there's already a denial: what's the exact reason, the case number, and my appeal deadline?”

Write down: who you talked to, the date and time, the reference number, and the exact words they used. You may need all four later.

### ➜ Not sure which rule set is yours? Use the on-page packet builder below. It matches your plan type, the message you got, the covered use, and whether this is a new request or renewal. Build my UnitedHealthcare Zepbound PA packet → No email. Do not enter your member ID, date of birth, records, labs, or an unredacted denial letter.

Build your UHC Zepbound prior authorization packet

Answer five questions, then match your answers to the table. This does not decide whether you qualify. It tells you which records and questions belong in your next step so you do not send a standard weight-loss packet into an OSA, Medicare, Medicaid, exclusion, or device problem.

Question 1: What kind of plan do you have?

• Employer or commercial UnitedHealthcare
• Individual-market UnitedHealthcare
• UHC Medicare with Part D drug coverage
• UHC Community Plan or Medicaid
• Not sure

Question 2: What exact message did you get?

• Prior authorization required
• Drug excluded or not a covered benefit
• Non-formulary
• More information needed
• Renewal denied
• Wrong product, quantity, or NDC
• Not sure

Question 3: Why was Zepbound prescribed?

• Weight management
• Moderate-to-severe obstructive sleep apnea
• Both
• Not sure

Question 4: Is this new or a renewal?

• First request
• Renewal before 52 weeks
• Renewal at 52 weeks or later
• Denial or appeal

Question 5: Which product was prescribed?

• Single-dose auto-injector pen
• Single-dose vial
• KwikPen
• Not sure

Match your answers to your lane

Your one-page prescriber cover sheet

Copy this into a note or print it:

Requested medication and device: Zepbound __________ Covered use: Weight management / OSA / Not confirmed Plan type: Commercial / Medicare / Community Plan / Unknown Exact pharmacy or plan message: ____________________ Policy or form named by plan: ____________________ Case number: ____________________ Initial or renewal: ____________________ Records the plan said are missing: ____________________ Submission path the plan gave us: ____________________ Decision or appeal deadline: ____________________

This is the micro-commitment that saves the most time: make the problem specific before anybody tries to solve it.

What are the UnitedHealthcare Zepbound prior authorization requirements?

Under UnitedHealthcare's standard 2026 commercial policy, the weight-management path uses a BMI of 30 or higher, or 27 or higher with a related condition, plus current lifestyle modification. Initial approval lasts six months. The policy says “older than 16,” but the FDA label remains adult-only, so anyone under 18 needs the prescriber and plan to resolve that conflict.

Here's the full list, in plain language, next to what your doctor actually has to send.

What counts as a weight-related condition?

The policy names four examples:

• High cholesterol or dyslipidemia
• High blood pressure or hypertension
• Type 2 diabetes
• Sleep apnea

These are examples, not a closed list. Your prescriber still needs to document why another condition is weight-related and relevant to the request.

Type 2 diabetes appearing on that list does not mean Zepbound is a diabetes treatment. Zepbound's FDA-approved uses are long-term weight management in eligible adults and moderate-to-severe obstructive sleep apnea in adults with obesity. Mounjaro is the tirzepatide brand approved for type 2 diabetes. If diabetes treatment is the real request, use the UnitedHealthcare Mounjaro Prior Authorization guide.

The lifestyle requirement is smaller than several guides make it sound

UnitedHealthcare's published policy says Zepbound is used “as an adjunct to lifestyle modification.” Adjunct means alongside.

The policy lists diet or calorie restriction, exercise, behavioral support, or a community-based program as examples. It does not state that you must finish a three- or six-month program before the first request.

Your chart should show what you are doing now. Do not invent a waiting period that the published policy does not contain. A member-specific plan can still add a rule, so ask for the actual text if somebody tells you to wait.

One detail worth planning around

In the same current policy, Zepbound gets a six-month initial approval. Wegovy gets five months.

Same insurer. Same policy. Different drug, different clock.

Put the Zepbound renewal date on your calendar as soon as approval starts. The baseline weight needs to survive the handoff from initial approval to renewal.

Does UnitedHealthcare require step therapy for Zepbound?

UnitedHealthcare's published standard Zepbound policy does not list a step-therapy requirement. In one 2026 Optum client formulary we checked, the Zepbound auto-injector has PA and quantity-limit flags but no ST flag. That is useful evidence, but it is not a promise for every employer or member-specific plan.

Step therapy means “try another drug first, prove it did not work or was not a fit, then ask for this one.”

The standard UHC policy we reviewed does not tell Zepbound patients to fail Wegovy or Saxenda first.

The Optum formulary key defines:

• PA — prior authorization
• QL — quantity limit
• ST — step therapy
• E — excluded
• ++ — coverage depends on plan benefit design

On the Eaton 2026 Premium Standard Formulary, the Zepbound auto-injector carries PA, ++, and QL. It does not carry ST.

The honest limit: another employer can use another formulary or add another utilization rule. If your denial letter says step therapy, do not argue from a generic article. Ask for the exact plan rule and answer that rule.

Step therapy and non-formulary are different problems

• Step therapy = the drug can be covered, but the plan wants another treatment tried first.
• Non-formulary = the product is not on the plan's list. The next step is a formulary-exception question, not a step-therapy override.
• Benefit exclusion = the plan does not include that benefit. More clinical records may not fix it.

Read the denial letter carefully. The words matter.

Is the Zepbound pen covered but the vial or KwikPen isn't?

Sometimes — but there is no single UnitedHealthcare device answer. We compared two published 2026 Optum client formularies and the Medicare GLP-1 Bridge. They point in different directions. A device or NDC mismatch can reject a claim even when the clinical PA is otherwise correct.

The device split we found

Same brand. Different device. Different program. Different answer.

This is why “Is Zepbound covered?” is not always specific enough.

What to do before you appeal

Ask the pharmacy for:

• The exact product name
• The exact NDC that rejected
• The rejection code or message
• Whether the PA was attached to another device

Then ask the plan:

“Which Zepbound device and NDC is covered under my benefit, and does the existing authorization apply to that exact product?”

A device correction may be faster than an appeal. But do not assume the auto-injector, vial, or KwikPen wins until you check your own list.

Can UnitedHealthcare cover Zepbound for sleep apnea if weight-loss drugs are excluded?

Yes, on certain commercial plans. UnitedHealthcare has a separate non-formulary policy for Zepbound in adults with obesity and moderate-to-severe obstructive sleep apnea. It can apply when weight-loss medications are otherwise excluded, but it asks for a full sleep-study and PAP packet, bars diabetes under its criteria, and uses a harder renewal test.

UnitedHealthcare says the quiet part out loud in its own policy. The document explains that medications used for weight loss are typically a benefit exclusion, then creates a separate program for Zepbound when obesity and OSA meet the policy.

That's the insurer confirming what you already suspected: the weight-loss door may be shut. This is a different door. Read the current OSA policy.

Zepbound is FDA-approved to treat moderate-to-severe obstructive sleep apnea in adults with obesity. This is not an off-label trick.

But the bar is high.

The complete sleep-apnea checklist

Your prescriber needs records supporting all of this:

• [ ] The request is for obstructive sleep apnea
• [ ] Age 18 or older
• [ ] BMI 30 or higher
• [ ] A sleep study
• [ ] An AHI, REI, or RDI of 15 or more events per hour
• [ ] At least one previous unsuccessful dietary effort to lose weight
• [ ] Either: continued OSA symptoms despite PAP adherence of at least 4 hours a night on at least 70% of nights — or documentation that the patient is not a PAP candidate
• [ ] Use with a reduced-calorie diet and increased physical activity
• [ ] No diabetes diagnosis and HbA1c below 6.5%
• [ ] Counseling on positional therapy
• [ ] Counseling to avoid alcohol and sedatives before bed
• [ ] No planned surgery for sleep apnea or obesity
• [ ] No predominant central or mixed sleep apnea, defined in the policy as central or mixed events making up 50% or more of all respiratory events
• [ ] Prescribed by a sleep specialist, or in consultation with one

First approval: 6 months.

That's fourteen requirements. A generic weight-loss request with a high BMI will not clear it. If you're going this way, build the packet for OSA from the start.

UHC's PDF contradicts itself on the symptom rule

The criteria section still asks for continued OSA symptoms despite PAP. But the change log says UnitedHealthcare removed the symptom requirement in December 2025.

Both statements sit in the same current PDF.

Until UnitedHealthcare posts a clean version, do not assume the requirement is gone. Ask which version the reviewer is applying. If current symptom and PAP records exist, include them rather than betting the request on the change log.

🔴 The honest thing nobody will tell you about this path

Every guide online wants to call sleep apnea the workaround. We want to be straight with you, because this is the part that can cost you coverage at renewal.

To renew Zepbound on the standard weight-loss path, you need to have lost 5% of your starting weight.

To renew on the sleep-apnea path, you need to have lost 10% — and your breathing test has to improve. At 52 weeks or later, the policy asks for a 50% decrease in AHI, REI, or RDI from baseline.

Double the weight-loss bar. Plus a second test you have to pass.

And if you have a diabetes diagnosis or HbA1c of 6.5% or higher, this UHC OSA policy shuts that door.

Now here's why that's still worth knowing rather than depressing.

None of this makes the sleep-apnea path bad. If your plan excludes weight-loss drugs, it may be the only commercial UHC insurance path that fits — and it is built around a real FDA-approved use. What it means is that you should walk in with your eyes open:

• Get the sleep study before the request
• Get a sleep specialist involved early
• Get the PAP report or the reason PAP is not a fit
• Get a dated starting weight in the chart on day one
• Ask when the follow-up sleep study should be done for renewal

A renewal can fail at month seven even when treatment is helping if nobody saved the baseline or planned the repeat study. That is not the patient failing. It is a packet built for the first approval and not the renewal.

If you need a new clinician

Your current prescriber is still the first choice when they have the chart and will handle the request. When that office cannot provide weight-management care or help with the paperwork, Sesame is a secondary option.

See Sesame Care's current weight-management plans → (affiliate link) Success by Sesame starts at $59 per month with an annual subscription or $99 month-to-month. Medication costs extra. Sesame says an insured patient's provider can assist with pre-authorization paperwork. Confirm the specific clinician will handle your UnitedHealthcare request and coordinate any sleep-specialist records before you book.

What records should your doctor send?

The strongest prior authorization packet matches your exact policy instead of sending a generic letter. At minimum, it needs the covered use, a dated BMI, any qualifying condition, your current lifestyle plan, the prescription details, and the exact device. Sleep-apnea requests and renewals each need a longer list.

Print this. Hand it over. It saves a round trip.

Standard weight-management packet

• Requested medication, dose, quantity, device, and NDC when available
• Exact diagnosis and covered use
• Dated height
• Dated starting weight — the baseline that matters later
• Current weight when relevant
• Calculated BMI
• The qualifying weight-related condition if BMI is 27–29.9
• Current reduced-calorie diet or nutrition plan
• Current physical-activity plan
• Behavioral support or community program when part of the plan
• Clinical reasoning
• Requested approval period
• The member-specific policy or electronic question set

Add this for a sleep-apnea request

• Full sleep-study report
• Baseline AHI, REI, or RDI
• PAP prescription
• PAP adherence report showing hours and percentage of nights
• Or documentation explaining why PAP is not a fit
• Current OSA symptom notes when available
• HbA1c result and diabetes-status documentation
• History of at least one unsuccessful diet effort
• Positional-therapy counseling note
• Alcohol-and-sedative counseling note
• Planned-surgery status
• Central or mixed apnea assessment
• Sleep-specialist consultation

Add this for renewal

Keep the original numbers. The reviewer needs to compare them.

What nobody should be inventing

We're going to be blunt, because this matters and it's your name on the chart.

Do not ask your prescriber to write:

• That you failed step therapy if you did not
• That you have sleep apnea without a sleep study
• A different starting weight than the chart shows
• A condition that isn't in your record
• That the request is urgent when it isn't
• That the prescription is for OSA when it is not
• A product or NDC different from what the clinician intends to prescribe

A false statement can sink the request and damage the relationship with your clinician. Every legitimate path on this page works with what is already true about you.

### ➜ Get the exact list for your situation Match your plan type, covered use, device, and request stage to the packet table above. Build my Zepbound prior authorization packet → Do not enter or send private medical information through this page.

Who submits the prior authorization, and which form do they use?

Your prescriber normally supplies and submits the clinical evidence. Many UnitedHealthcare pharmacy benefits are managed by Optum Rx, but you should confirm the pharmacy benefit manager on your card or portal. Optum Rx prefers electronic prior authorization, offers phone submission at 1-800-711-4555, and is retiring most pharmacy-PA fax numbers.

Start with the doctor you already have

Before you go looking for a new provider: your current prescriber is usually the fastest path. They already have the diagnosis, chart, measurements, and history. They can answer the reviewer's follow-up questions without starting from zero.

Switching clinicians just to get a form filled out often means redoing work that already exists.

Call the office and ask:

“Who handles prior authorizations here, and what do you need from me?”

Some practices have a dedicated person. Some don't, and that's when another care path may make sense.

The current submission paths

1. Electronic prior authorization: Optum Rx says ePA can be used to submit, manage, and track prior authorizations, step-therapy requests, and non-formulary exceptions.
2. Phone: A provider can call 1-800-711-4555 to submit a verbal PA request.
3. Current paper form: Optum Rx still offers a printable request form when electronic submission is not possible.
4. Urgent requests: Optum Rx tells providers to call the same number. Urgency must be real and supported by the clinical situation.

Don't go hunting for one old fax number

Optum Rx says it is retiring most fax numbers used for pharmacy prior authorizations, except for certain processes in Massachusetts, Rhode Island, South Carolina, and Texas.

If the office is working from an old cheat sheet, confirm that the fax is still valid. Electronic submission is the safer default.

There is no universal UHC Zepbound PA form

The right questions can change with the plan, state, line of business, covered use, and product. A generic form downloaded from a blog may not match the member's electronic request.

That's why the plan-specific ePA path is better than guessing.

What you can do while the clinical request is being handled

• Confirm the benefit status
• Confirm the covered device and NDC
• Get the case or reference number
• Ask whether anything is missing
• Track the status
• Request any denial in writing
• Record the appeal deadline the moment you get it

### ➜ Still don't know whether your plan covers it? Ro's free GLP-1 Insurance Coverage Checker contacts your insurer and sends a report on the standard Ozempic, Wegovy, and Zepbound pens, including whether prior authorization appears required. Check your UnitedHealthcare Zepbound coverage free → (affiliate link) What it does and doesn't do: Ro contacts the insurer for coverage information. It does not submit a treatment request or write a prescription. It currently cannot check coverage for Zepbound KwikPen, Foundayo pill, or Wegovy pill. Ro Body is separate from the free checker. Get started for $39, then as low as $74 per month with an annual plan paid upfront. The monthly option is $149. Medication is billed separately. Ro says membership includes an insurance concierge; coverage is never guaranteed.

How long does UnitedHealthcare take to approve Zepbound?

There is no single verified commercial UnitedHealthcare turnaround time that applies to every member. Optum Rx says missing information can delay or prevent a decision, so get the case number and ask what deadline applies to your request. Medicare Part D has federal limits: generally 72 hours for a standard coverage determination and 24 hours for an expedited one.

We looked for a current universal commercial number. We did not find one we would stake this page on.

What can slow the request down

• The plan has not received the request
• The request went to the wrong pharmacy benefit manager
• The device or NDC does not match the benefit
• The diagnosis or covered use is unclear
• Baseline BMI is missing
• The related condition is missing for BMI 27–29.9
• The OSA packet lacks the sleep study, PAP report, HbA1c, or specialist note
• The plan asked for more information and nobody answered

Optum Rx warns that failure to provide the required clinical information may delay processing or cause denial.

What to ask after submission

“Was the request received? Is anything missing? What's the case number? Which policy is being used? What deadline applies to this request?”

Write down the answers.

If you're on Medicare Part D

Federal Part D rules generally require a plan to decide a standard coverage request within 72 hours and an expedited request within 24 hours. When the request is an exception that needs a prescriber's supporting statement, the clock begins when the plan receives that statement.

About expedited requests

Don't call every request urgent. Expedited review is for cases where waiting under the standard timeline could seriously harm the patient's life or health. That determination belongs with the plan's rule and the clinician's honest judgment.

Why was your UnitedHealthcare Zepbound prior authorization denied?

The exact wording on the denial determines your next move. A missing record gets corrected. A criterion failure gets answered. A product mismatch gets fixed at the device or NDC level. A true benefit exclusion usually cannot be reversed by sending the same BMI notes again.

Find your denial reason. Do the thing in the third column.

Get these five things before you do anything

1. The full written denial — not a phone summary
2. The case or authorization number
3. The exact reason in the plan's words
4. The specific criterion the plan says was missed
5. The appeal deadline

If a phone representative gives you a reason verbally, ask for the written notice too.

Correction, reconsideration, appeal, or a new request?

These are different things, and “appeal” is not always the fastest one.

• Correction — the record exists, but it did not get sent or the product was entered wrong.
• Reconsideration or added information — the case is still open and the plan will take clarification.
• Appeal — the plan issued an adverse determination and you are formally contesting it.
• New request — the authorization expired or the clinical facts changed.

Ask which path is open on your case before starting from zero.

How do you appeal a UnitedHealthcare Zepbound denial?

Start with the denial notice because it gives the deadline, destination, and rights for your exact plan. For many non-Medicare employer and marketplace plans, federal guidance gives at least 180 days for an internal appeal. If internal appeal fails, external review may be available and is generally decided within 45 days, or within 72 hours when expedited.

Use the denial letter, not a generic timeline, as the controlling instruction.

The appeal structure that stays on point

1. Identify the member, drug, device, case number, and denial date.
2. State exactly what determination is being appealed.
3. Name the policy or criterion the plan used.
4. Point to the exact record that satisfies it.
5. Address the stated denial reason head-on.
6. Ask for reversal and coverage.
7. List every attachment.
8. Keep proof of when and how it was sent.

Don't fill an appeal with general information about obesity when the denial was about a missing sleep study, a benefit exclusion, or a wrong NDC. Answer the thing the plan actually said.

Commercial deadlines

• Internal appeal: many employer and marketplace plans give at least 180 days after the denial notice. Follow the date in your notice.
• External review: federal guidance says standard review is decided as soon as possible and no later than 45 days after receipt; expedited external review is no later than 72 hours, or sooner when medical urgency requires it.

Medicare Part D is different

A Medicare Part D redetermination request generally must be filed within 65 calendar days from the coverage-determination notice. The plan then generally has 7 calendar days for a standard redetermination or 72 hours for an expedited one.

Do not use the commercial 180-day number for Medicare.

The Medicare GLP-1 Bridge is different again

The Bridge does not have an appeal process. CMS says the prescriber can resubmit the form when information was wrong, updated, or missing.

Keep everything

Screenshots. Portal messages. Submission confirmations. Reference numbers. Names. Dates. Every attachment.

Appeals get decided on the record. “I think I sent that” is not a record.

What does UnitedHealthcare require to renew Zepbound?

Renewal is a separate test. On the standard weight-loss path, the current policy asks for at least 5% loss from baseline plus continued lifestyle modification, then gives 12 months. On the OSA path, it asks for at least 10% loss plus documented breathing-test improvement, with a 50% improvement required at 52 weeks or later.

This is the section most guides skip. It's also the one that can interrupt treatment after the first approval.

The starting weight is the whole game

We want to be blunt because this is fixable now and hard to reconstruct later.

The reviewer is not only looking at what you weigh today. They need the starting weight, with a date, and the current weight, with a date.

If the chart does not preserve the true baseline, the required percentage cannot be shown cleanly.

Ask today: “Is my starting weight and the date documented in my chart?”

What 5% and 10% look like

The math is simple. The proof is what gets lost.

Start early

Ask the prescriber's office when it begins renewal paperwork and what current measurements it needs. For the OSA path, ask who will order and interpret the repeat sleep study.

Do not wait for the pharmacy to decline a refill before you learn the authorization expired.

What if Zepbound is truly excluded from your plan?

A true benefit exclusion is different from a denied prior authorization, and more paperwork may not change it. Confirm the exclusion in writing, check whether the OSA, Medicare, state, employer, or formal-exception path applies, then compare legitimate FDA-approved cash-pay options. LillyDirect currently starts Zepbound at $299 per 28-day supply.

If the plan confirms in writing that the requested benefit is excluded and no separate covered use fits, stop sending the same packet.

You're not failing at paperwork. You're running into a benefit decision.

That's not your fault, and it is not fixed by making the letter longer.

Check these before you stop pursuing coverage

• The OSA pathway, when the diagnosis and records truly fit
• Regular Medicare Part D for the OSA indication
• The Medicare GLP-1 Bridge for eligible weight-management use
• A state Medicaid or state-law path
• A formal formulary or benefit exception, when the plan offers one
• An employer-benefits escalation
• Another FDA-approved medication that is actually covered and medically appropriate

Cash-pay Zepbound, if it comes to that

LillyDirect currently lists these starting self-pay prices:

If the higher doses are not refilled within 45 days, Lilly lists regular prices of $499 for 7.5 mg and $699 for 10, 12.5, and 15 mg. The program is self-pay, not insurance.

Full breakdown: Zepbound Self-Pay Price 2026 and Zepbound Savings Card 2026.

One line we won't cross

We're not going to point you toward compounded tirzepatide as though it were Zepbound. You came to this page trying to get an FDA-approved brand covered by insurance.

Compounded tirzepatide is not Zepbound. FDA explains that compounded drugs are not FDA-approved finished products and are not reviewed for safety, effectiveness, or quality before marketing.

If you want to compare every treatment path — covered, cash-pay, FDA-approved, and compounded — use Find My GLP-1 Path. It keeps the categories separate.

Do Medicare and Community Plan members follow the same rules?

No. UnitedHealthcare commercial plans, regular Medicare Part D, the Medicare GLP-1 Bridge, and state Community Plan products use different benefits, forms, deadlines, products, and clinical criteria. Nothing in the commercial tables above should be treated as final for a Medicare or Medicaid member.

UnitedHealthcare Medicare: two separate paths

Regular Part D for OSA. Zepbound prescribed for moderate-to-severe OSA is a covered-use question under Part D, subject to the member's formulary and PA rules. Ask: “Is this being processed as a Part D coverage determination for the OSA indication?”

The Medicare GLP-1 Bridge for weight management. This is a separate CMS demonstration running from July 1, 2026 through December 31, 2027. Eligible beneficiaries pay a $50 copay outside the ordinary Part D payment flow.

Medicare GLP-1 Bridge eligibility

A prescriber must attest that the drug is for weight reduction and ongoing lifestyle modification, and that the beneficiary is at least 18 and meets one of these starting-BMI paths:

• BMI 35 or higher, or
• BMI 30 or higher plus heart failure with preserved ejection fraction, uncontrolled hypertension under CMS's definition, or chronic kidney disease stage 3a or higher, or
• BMI 27 or higher plus prediabetes, previous heart attack, previous stroke, or symptomatic peripheral artery disease

CMS says the BMI is measured at the time GLP-1 therapy was started, not only at the Bridge application date.

The Bridge uses Zepbound KwikPen only

For Zepbound, the Bridge includes the KwikPen. It excludes the single-dose vial and single-dose pen.

That is the opposite of at least one commercial Optum formulary we reviewed. The device is not a footnote. It is part of eligibility.

The Bridge is pharmacy-first

Under the CMS provider process, the pharmacy sends the claim to the Bridge. That claim triggers the PA request to the prescriber. CMS warns that sending a PA before the pharmacy claim can fail to find the patient in the system.

CMS says the Bridge decision is sent within 72 hours of submission. There is no appeal process, but corrected or updated information can be resubmitted.

OSA, diabetes, and MASH do not go through the Bridge

The Bridge is for weight-management use. CMS directs type 2 diabetes, moderate-to-severe OSA, and qualifying MASH uses to the regular Part D plan instead.

Full details: Medicare GLP-1 Bridge: $50 per month Through 2027 and Does Medicare Cover Zepbound?.

UnitedHealthcare Community Plan and Medicaid

Coverage is state-specific. The state's preferred drug list, benefit rules, and prior authorization form control.

Do not copy the commercial BMI table onto a Community Plan request. Start with Does Medicaid Cover Zepbound? and then open your state's current source.

Your doctor, Ro, or Sesame — who should handle this?

Start with the prescriber you already have because that office holds the chart the request needs. Ro is useful when you first need a free coverage report or want a paid telehealth program with an insurance concierge. Sesame is a secondary option when you need a new clinician and want the program price before you commit.

Provider-stated versus verified on August 6, 2026

Note that the first row is usually the fastest and is the one we do not get paid for. We're leaving it first on purpose.

What people are actually asking

Real reader language, so you know you're not the only one refreshing a portal late at night.

One r/Zepbound thread is simply titled “Any luck getting approved with United Healthcare?” followed by: “Any tips or things I should look into?”

That's the whole experience in a few words. Not “is this drug good?” Just: did anyone else get through, and what did they do differently?

This is reader language, not evidence. Somebody else's approval does not predict yours, and a forum post does not change your policy. The useful answer is usually less dramatic: find the right policy, send the right packet, confirm the exact product, and save the baseline before renewal.

Your next six steps

1. Copy the exact wording from the pharmacy rejection or denial letter.
2. Confirm whether the benefit exists for the use your prescriber requested.
3. Identify your rule set: standard, North Dakota, OSA, Medicare, Medicaid, or device mismatch.
4. Build the right packet — initial, OSA, renewal, correction, or appeal.
5. Have the prescriber use the current member-specific submission path.
6. Save the case number, baseline, product, and deadline. Every time.

### ➜ Still not sure which path fits you? Still not sure which GLP-1 program is right for you? Take our free two-minute matching quiz. You'll get a personalized action plan based on your state, insurance, formulation preference, treatment path, and budget — with source-verified pricing.

Frequently asked questions

Does UnitedHealthcare cover Zepbound?

Some UnitedHealthcare plans cover Zepbound with prior authorization. The standard weight-loss program is optional, a narrow North Dakota rule uses a different BMI threshold, and a separate OSA policy can apply to certain plans that exclude ordinary weight-loss drugs.

Does every covered UnitedHealthcare Zepbound request need prior authorization?

The current standard policy is titled Prior Authorization/Notification, while the separate OSA policy is Prior Authorization/Non-Formulary. Your member-specific benefit and electronic claim determine whether the standard path is handled as prior authorization, notification, or another plan-specific process.

What BMI does UnitedHealthcare require for Zepbound?

The standard commercial policy uses BMI 30 or higher, or BMI 27 or higher with a related condition. The named North Dakota fully insured EHB small-group and individual section uses BMI 40. The separate OSA path uses BMI 30 plus the full OSA criteria.

Can a 17-year-old meet UnitedHealthcare's Zepbound policy?

UHC's policy says older than 16, but the FDA label covers adults and says safety and effectiveness are not established in pediatric patients. A 17-year-old should not treat the UHC line as routine on-label eligibility; the prescriber and plan need to resolve it.

Does UnitedHealthcare require step therapy for Zepbound?

The current published standard policy does not list step therapy. One Optum 2026 client formulary we reviewed also has no ST flag on the auto-injector. A member-specific employer plan can still use a different rule, so the denial and formulary control.

Is there one UnitedHealthcare Zepbound prior authorization form?

No universal paper form works for every UHC member. The plan, pharmacy benefit manager, state, line of business, covered use, and product can change the question set. Electronic submission is the preferred Optum Rx path.

Which Optum Rx phone number handles prior authorization?

Optum Rx currently lists 1-800-711-4555 for verbal PA requests and urgent requests. The provider should still confirm that Optum Rx manages the member's pharmacy benefit.

How long does UnitedHealthcare take to approve Zepbound?

No universal commercial UHC turnaround was verified. Medicare Part D generally uses 72 hours for a standard coverage determination and 24 hours for an expedited one. The Bridge sends decisions within 72 hours. Ask for the deadline on your exact commercial case.

Does UnitedHealthcare cover Zepbound for sleep apnea?

Certain commercial plans do through a separate policy for adults with obesity and moderate-to-severe OSA. It requires BMI 30, a sleep study with AHI, REI, or RDI of 15 or more, PAP history or lack of candidacy, no diabetes under the policy, HbA1c below 6.5%, and sleep-specialist involvement.

What if UHC's OSA policy change log conflicts with the criteria?

Ask which version the reviewer is applying and include the records when they exist. The current PDF's criteria still ask for ongoing symptoms despite PAP, while its change log says that requirement was removed in December 2025.

Can I get Zepbound if my plan excludes weight-loss drugs?

Possibly, when another covered path fits — such as UHC's OSA policy, regular Medicare Part D for OSA, the Medicare GLP-1 Bridge for eligible weight-management use, or a state-specific rule. A true exclusion without another covered path usually cannot be fixed by resending the same records.

Is the Zepbound pen covered when the vial is excluded?

It depends on the exact formulary. One 2026 Optum client list covers the auto-injector at Tier 2 with PA and excludes the vial. Another published Optum list excludes both “Zepbound” and “Zepbound KwikPen.” The Medicare Bridge covers KwikPen but not the single-dose pen or vial.

How long does a UnitedHealthcare Zepbound approval last?

The current standard and OSA policies each list six months for initial approval. Standard renewal is 12 months. OSA renewal is six months before 52 weeks of consecutive therapy and 12 months at 52 weeks or later.

What does UnitedHealthcare require to renew Zepbound?

The standard path asks for at least 5% loss from documented baseline plus continued lifestyle modification. The OSA path asks for at least 10% loss plus breathing-test improvement; at 52 weeks or later, the policy asks for a 50% decrease in AHI, REI, or RDI.

Why did UnitedHealthcare deny my Zepbound prior authorization?

Common categories include benefit exclusion, missing records, criterion not met, wrong covered use, non-formulary status, member-specific step therapy, renewal failure, wrong product or NDC, or a request sent through the wrong channel. The written denial tells you which fix belongs to your case.

Does UnitedHealthcare cover Zepbound for type 2 diabetes?

Zepbound is not FDA-approved to treat type 2 diabetes. Diabetes can appear as a weight-related condition under the standard BMI 27 path, but that is different from using Zepbound as a diabetes drug. Mounjaro is the tirzepatide brand approved for type 2 diabetes.

Can Ro submit a UnitedHealthcare Zepbound prior authorization?

Ro's free coverage checker does not submit the treatment request. Ro says its paid Body membership includes an insurance concierge that helps with coverage paperwork. The plan still makes the decision, and membership does not guarantee approval.

Can Sesame help with a Zepbound prior authorization?

Sesame says an insured patient's provider can assist with pre-authorization paperwork. Confirm that the clinician you choose will handle your UHC form, records, and follow-up before booking.

Related guides

• UnitedHealthcare Mounjaro Prior Authorization — the diabetes path
• UnitedHealthcare Ozempic Prior Authorization
• Zepbound Self-Pay Price 2026
• Zepbound Savings Card 2026
• Does Insurance Cover Zepbound for Sleep Apnea?
• Does Medicare Cover Zepbound?
• Does Medicaid Cover Zepbound?
• Is Zepbound Safe?
• Find My GLP-1 Path

Sources

1. UnitedHealthcare Pharmacy — Program 2026 P 1114-21, Plans with Weight Loss/Appetite Suppression Medication Coverage, effective July 1, 2026
2. UnitedHealthcare Pharmacy — Program 2025 P 1475-2, Zepbound Obstructive Sleep Apnea Only, effective March 1, 2026
3. DailyMed — Current Zepbound Prescribing Information
4. Optum Rx — Prior Authorization Guidelines and Procedures
5. Optum Rx — 2026 Eaton Premium Standard Formulary
6. Optum Rx — 2026 State of Michigan Premium Formulary
7. CMS — Medicare Part D Coverage Determinations
8. CMS — Redetermination by the Part D Plan Sponsor
9. CMS — Medicare GLP-1 Bridge
10. CMS — Medicare GLP-1 Bridge Information for Providers
11. HealthCare.gov — Internal Appeals
12. HealthCare.gov — External Review
13. Ro — Free GLP-1 Insurance Coverage Checker
14. Ro — Weight Loss Program Pricing
15. Sesame — Online Weight Loss Program
16. LillyDirect — Zepbound
17. FDA — Understanding the Risks of Compounded Drugs

This page explains insurance rules. It is not medical advice or a coverage determination. Your plan documents and clinician's judgment control your situation. The current Zepbound label says the boxed warning is based on thyroid C-cell tumors found in rats; whether Zepbound causes these tumors in humans is unknown. Zepbound is contraindicated in people with a personal or family history of medullary thyroid carcinoma or MEN 2. Talk to your prescriber about the full label and whether Zepbound fits your medical history.